A mixed glucocorticoid/mineralocorticoid selective modulator with dominant antagonism in the male rat brain.
Atucha et al. • 2015 • Endocrinology. 2015;156(11):4105-4114.
This author has not written his bio yet.
But we are proud to say that jeremiah@devisedesigns.com contributed 136 entries already.
Atucha et al. • 2015 • Endocrinology. 2015;156(11):4105-4114.
Hunt et al. • 2017 • J Med Chem. 2017;60(8):3405-3421.
Clark et al. • 2008 • Bioorg Med Chem Lett. 2008;18(4):1312-7.
Hunt et al. • 2017 • Clin Pharmacol Drug Dev. 2017 Oct 2. doi: 10.1002/cpdd.389.
Bali et al. • 2016 • J Clin Endocrinol Metab. 2016;101(11):4305-4312.
Kach et al. • 2017 • Mol Cancer Ther. 2017;16(8):1680-1692.
Conzen SD • 2008 • Mol Endocrinol.2008;22(10):2215-28.
Isaacs JT • 1999 • Urol Clin North Am. 1999;26(2):263-73.
Stringer-Reasor et al. • 2015 • Gynecol Oncol. 2015;138(3):656-62.
Isikbay et al. • 2014 • Horm Cancer. 2014;5(2):72-89.
© 2024 Corcept Therapeutics, Incorporated